ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1926

Cardiac Remodeling in Systemic Sclerosis: TGF-β/Fra2-Dependent Autophagy As a Novel Target for Heart Fibrosis

Mara Stellato1, Michal Rudnik1, Florian Renoux1, Elena Pachera1, Karl Sotlar2, Karin Klingel3, Joerg C. Henes4, Przemyslaw Blyszczuk1,5, Oliver Distler1 and Gabriela Kania1, 1Department of Rheumatology, Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Institute of Pathology, Ludwig Maximilians University, Munich, Germany, 3Department of Molecular Pathology, University Hospital Tuebingen, Tuebingen, Germany, 4Department of Internal Medicine II, Division of Rheumatology, University Hospital Tuebingen, Tuebingen, Germany, 5Department of Clinical Immunology, Jagiellonian University Medical College, Krakow, Poland

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: autophagy, fibrosis, heart disease and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics I

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:

SSc patients frequently suffer from primary cardiac involvement. The main histological feature is fibrosis, but the mechanisms responsible for the heart failure remain unclear. It is known that cellular progenitors, including stromal cells, differentiate into myofibroblasts and autophagy may favor fibrosis through enhanced differentiation of cardiac stromal cells. Here we describe the role of Fos-related antigen 2 (fra-2)/autophagy crosstalk in TGFβ-dependent myocardial fibrosis in SSc.

Methods:

Immunohistochemistry (IHC) and immunofluorescence (IF) were performed on endomyocardial biopsies (EMBs) from SSc patients and hearts from fra-2tg SSc mouse model and WT mice. Myocardial stromal Ter119–CD45–CD31– (Lin–) gp38+ stromal cells were sorted for in vitro culture. The cellular phenotype was assessed by qPCR, IF, stress fiber staining, SIRCOL and contraction assay on sorted cells. The antisense oligonucleotide GapmeR was used to knock-down fra-2.

Results:

Fibrosis, collagen deposition and αSMA+ myofibroblasts were increased in the myocardium of SSc patients (n=10). Fra-2 and autophagy markers such as LC3B, Beclin-1 and Atg5 were expressed in fibrotic cardiac tissues. In parallel, the myocardium of fra-2tg mice showed higher expression of the profibrotic markers αSMA, vimentin and collagen I compared to WT mice (n=5), as well the expression of LC3B and Beclin-1 in fibrotic regions. Among cardiac stromal cells (Lin–), the frequency of gp38+ cells was significantly higher in fra2tg myocardium compared to WT mice (n=8, p=0.02). Lin–/gp38+ cells co-expressed αSMA, vimentin and collagen I together with LC3B and Beclin-1 (n=3). Following TGFβ stimulation, WT Lin–/gp38+ cells entered fibroblast-to-myofibroblast transition characterized by increased mRNA and protein levels of αSMA, collagen I, fibronectin (n=3-6), formation of αSMA+ fibers and stress fibers (n=3), increased cell proliferation (n=5; p=0.04), contraction capability (n=5; p<0.05) and collagen secretion (n=5; p=0.04). TGFβ stimulation of WT Lin–/gp38+ cells induced the expression of LC3B, Beclin-1 and Atg5 at mRNA and protein level (n=3-5). Accordingly, TGFβ inhibition caused the downregulation of these markers (n=3). In contrast to WT cells, fra-2tg Lin–/gp38+ cells showed the presence of αSMA+ fibers, stress fibers and an increased contraction capability even without TGFβ stimulation.
Finally, fra-2 silencing resulted in decreased Lin–/gp38+ cell differentiation and autophagy activity as following: levels of αSMA and collagen I (n=5; p=0.007), secreted collagens (n=5; p<0.05) and αSMA fibers (n=3) were significantly downregulated in addition to a significant decrease of mRNA and protein expression of LC3B, Beclin-1 and Atg5 (n=3).

Conclusion:

The TGFβ/fra-2 axis regulates the autophagy process, leading in turn to stromal-to-myofibroblast transition. Therefore, targeting autophagy might ameliorate the fibrotic process during heart remodeling in SSc.


Disclosure: M. Stellato, None; M. Rudnik, None; F. Renoux, None; E. Pachera, None; K. Sotlar, None; K. Klingel, None; J. C. Henes, None; P. Blyszczuk, None; O. Distler, Actelion, Bayer, BiogenIdec, Boehringer Ingelheim, ChemomAb, espeRare foundation, Genentech/Roche, GSK, Inventiva, Lilly, medac, MedImmune, Mitsubishi Tanabe Pharma, Pharmacyclics, Novartis, Pfizer, Sanofi, Sinoxa and UCB, 2,Actelion, Bayer, BiogenIdec, Boehringer Ingelheim, ChemomAb, espeRare foundation, Genentech/Roche, GSK, Inventiva, Lilly, medac, MedImmune, Mitsubishi Tanabe Pharma, Pharmacyclics, Novartis, Pfizer, Sanofi, Sinoxa and UCB, 5,mir-29 for the treatment of systemic sclerosis, 9; G. Kania, Bayer, 2.

To cite this abstract in AMA style:

Stellato M, Rudnik M, Renoux F, Pachera E, Sotlar K, Klingel K, Henes JC, Blyszczuk P, Distler O, Kania G. Cardiac Remodeling in Systemic Sclerosis: TGF-β/Fra2-Dependent Autophagy As a Novel Target for Heart Fibrosis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/cardiac-remodeling-in-systemic-sclerosis-tgf-%ce%b2fra2-dependent-autophagy-as-a-novel-target-for-heart-fibrosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cardiac-remodeling-in-systemic-sclerosis-tgf-%ce%b2fra2-dependent-autophagy-as-a-novel-target-for-heart-fibrosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology